Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/17/2024 | $20.00 | Neutral | Analyst |
| 11/6/2024 | $22.00 → $19.00 | Buy → Neutral | BofA Securities |
| 10/11/2024 | $24.00 | Overweight | KeyBanc Capital Markets |
| 8/12/2024 | $22.00 | Buy | BofA Securities |
| 8/12/2024 | $18.00 | Buy | Loop Capital |
| 8/12/2024 | $24.00 | Overweight | Stephens |
| 8/12/2024 | $21.00 | Buy | Citigroup |
| 8/12/2024 | $23.00 | Outperform | RBC Capital Mkts |
4 - Ardent Health Partners, Inc. (0001756655) (Issuer)
Analyst resumed coverage of Ardent Health Partners with a rating of Neutral and set a new price target of $20.00
BofA Securities downgraded Ardent Health Partners from Buy to Neutral and set a new price target of $19.00 from $22.00 previously
KeyBanc Capital Markets initiated coverage of Ardent Health Partners with a rating of Overweight and set a new price target of $24.00
4 - Ardent Health Partners, Inc. (0001756655) (Issuer)
3 - Ardent Health Partners, Inc. (0001756655) (Issuer)
4 - Ardent Health Partners, Inc. (0001756655) (Issuer)